updated 5/10/2011 6:16:57 PM ET 2011-05-10T22:16:57

PHOENIX, May 10, 2011 (GLOBE NEWSWIRE) -- PEPID, the leading provider of developer drug data and clinical decision support information and technology for healthcare systems and professionals, today announced the addition of duplicate therapy checking to its robust drug interaction checker.

"As more and more drugs come on the market with multiple uses, and off label uses become more commonplace checking for duplicate therapy between medications is crucial, and must be considered in medication administration and prescribing." says John Wagner, PEPID president. "We are excited to offer this new functionality to our users, as we continue to offer the full spectrum of clinical decision support through the PEPID Knowledge Base."

PEPID's drug interaction checker provides alerts for duplicate therapy on three different levels — therapeutic class, pharmacologic class and the ingredient level — making it the most comprehensive on the market today. This is in addition to the drug-drug, drug-allergy, drug-food and drug-herbal checks already available — solidifying the company's position as the largest and most authoritative drug database on the market.

The duplicate therapy check will allow electronic medical record or pharmacy information systems to give users a warning if a duplicate therapy exists. This functionality helps to meet the requirements for meaningful use reimbursements.

"Our enhanced drug interaction checker functions allows system developers to use our software development kit to easily create customized alerts for duplicate therapy, drug allergy reactions and drug interactions." says Edward Reynolds, PEPID chief technology officer. "Our drug interaction methods can be implemented with about 10 lines of code, which greatly reduces development time so EMR providers can release this critical functionality quickly."

System developers can use the PEPID software development kit and APIs to programmatically receive critical drug information monographs, dosing calculators, drug interaction, drug-allergy or duplicate therapy information.

PEPID's reputable clinical and pharmacological content is designed to support clinicians through every stage of the decision support process, increasing safety and accuracy through better-informed patient care, and this latest module adds to the robust content and tools available, and helps to meet meaningful use criteria in electronic medical records (EMR) systems.

Learn more at pepid.com.

Contact: Jenna Reynolds
Phone: (888) 321-7828 x211
Email: press@pepid.com

About PEPID LLC

PEPID utilizes cutting-edge technology to deliver clinical decision-support resources specific for healthcare professionals including pharmacists, doctors, nurses, EMTs and students.

PEPID content is reviewed and contributed to by partners including the American Academy of Emergency Medicine, the National Association of Emergency Medical Services Educators, the Family Physician Inquiries Network, the National Association of Clinical Nurse Specialists, the Oncology Nursing Society, and the American Society of Health-System Pharmacists to ensure content is of the highest quality.

This information was brought to you by Cision http://www.cisionwire.com

http://www.cisionwire.com/pepid/r/pepid-launches-duplicate-therapy-checker,g9120870

The following files are available for download:

wkr0005.pdf PDF

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.94%
$30K home equity loan FICO 5.19%
$75K home equity loan FICO 4.58%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.40%
13.40%
Cash Back Cards 17.92%
17.91%
Rewards Cards 17.12%
17.11%
Source: Bankrate.com